Table 3.
CMR findings systemic sclerosis (SSc)
| Controls (n = 20) | Patients (n = 17) | P | |
|---|---|---|---|
| LV-EF (%) | 66 ± 4 | 62 ± 16 | 0.48 |
| LV-EDV (ml) | 109 ± 28 | 105 ± 29 | 0.82 |
| LV-ESV (ml) | 37 ± 13 | 38 ± 14 | 0.87 |
| LV-SV | 71 ± 16 | 67 ± 16 | 0.63 |
| LV-EDD | 45 ± 5 | 46 ± 4 | 0.42 |
| LA (cm2) | 20 ± 4 | 20 ± 5 | 0.93 |
| IVS (mm) | 10 ± 2 | 10 ± 4 | 0.76 |
| PA (mm) | 24 ± 4 | 26 ± 8 | 0.81 |
| LV mass (g) | 76 ± 18 | 81 ± 31 | 0.82 |
| LGE per patient | - | 2 (12 %) | |
| Epicardial | - | - | |
| Intramural | - | 2 (12 %) | |
| Transmural | - | - | |
| Subendocardial | - | - | |
| % LV mass | - | 1.3 | |
| Native T1 (ms) | 962 (947–987) | 1031 (1007–1075) | <0.001 |
| Post contrast T1 (ms) | 526 (508–553) | 494 (474–525) | 0.02 |
| ECV (%) | 25 (24–27) | 31 (28–34) | <0.001 |
| T2 (ms) | 49 (48–51) | 58 (54–59) | <0.001 |
All values are n or mean ± SD or interquartile ranges
CMR cardiac magnetic resonance, LV left ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume